William Janzen,
Professor,
The University of North Carolina at Chapel Hill
William P. Janzen is the Director of Assay Development and Compound Profiling in the Center for Integrative Chemical Biology and Drug Discovery. Mr. Janzen has twenty years of experience in innovative drug discovery and has been a leader in high throughput screening for lead generation in startup and large pharmaceutical ventures. He has held executive and operational positions in the pharmaceutical industry including President and Chief Operating Officer of Amphora Discovery and Director of Lead Generation Technologies at Eli Lilly and Company.
|
|
Kinases as Targets for Drug Discovery in an Academic SettingWednesday, 18 June 2014 at 14:00  Add to Calendar ▼2014-06-17 00:00:002014-06-17 01:00:00Europe/LondonDrug Discovery and Development - Online Event in VirtualVirtualSELECTBIOenquiries@selectbiosciences.comThe operations of the CICBDD with specific focus on novel kinase projects will be discussed.
|
